The News Caravan

Tag: diseases

  • World Glaucoma Week: DHSK conducts screening for non-communicable diseases at Gousia Hospital Khanyar, 29 patients diagnosed wit

    [ad_1]

    DHSK urges citizens to take preventive measures against chronic diseases

    Rehan Qayoom Mir

    Srinagar, Mar 13 (GNS): In sync with the ongoing Glaucoma Week, a screening camp for non-communicable diseases was on Monday held at Government Gousia Hospital Khanyar, during which 29 patients were diagnosed with diabetes.

    To overlook the ongoing celebrations, Director Health Services Kashmir Dr. Mushtaq Ahmad Rather visited Government Gousia Hospital Khanyar Srinagar – where he assessed a screening camp conducted for non-communicable diseases.

    Talking to media on the sidelines of the event, Dr. Mushtaq Ahmad Rather, as per GNS said, that in a significant move towards the prevention and management of non-communicable diseases (NCDs), the Government of India’s HNCD program has initiated screening in all district hospitals for people of all age groups. “The screenings aim to identify individuals who may be at risk for chronic diseases such as diabetes and hypertension.”

    Citing reports, Rather said that out of the 550 patients screened at Gousia Hospital, 29 were diagnosed with high blood sugar levels, indicating that they are at a good percentage of fighting the disease. “This is in line with the national average, which reports that 12-13% of the population is diabetic,” he said.

    “It is crucial for people to change their lifestyle as no other option is left now. They need to exercise, work on their fitness, and reduce the consumption of salt, sugar, and other harmful elements,” said the Director of Health, emphasizing the need for people to take preventive measures seriously.

    “The rise of chronic diseases such as hypertension and diabetes is becoming a concern across India, prompting the government to initiate the NCB program. The aim is to educate people on how to remain healthy and enjoy a better quality of life.”

    Talking about the outbreak of seasonal influenza on the rise, the Director urged people to take all the necessary precautions and use masks to protect themselves from the virus.”

    He advised those experiencing influenza symptoms to drink hot water and consult a doctor immediately.

    “We have taken preventive measures, and if anybody among us feels symptomatic, they should consult a doctor. Otherwise, there is no need to worry, taking proper prevention can cure anyone,” he reassured.

    “This initiative by the HNCD program is a step in the right direction towards creating awareness and promoting preventive measures for NCDs. With such screenings becoming more common, early detection and management of these diseases could save lives and improve the health of the nation,” he added. (GNS)

    [ad_2]
    #World #Glaucoma #Week #DHSK #conducts #screening #noncommunicable #diseases #Gousia #Hospital #Khanyar #patients #diagnosed #wit

    ( With inputs from : thegnskashmir.com )

  • Hyderabad: Serum Institute to set up CoE for infectious diseases, pandemic preparedness

    Hyderabad: Serum Institute to set up CoE for infectious diseases, pandemic preparedness

    [ad_1]

    Hyderabad: Serum Institute of India on Sunday announced establishment of a Dr Cyrus Poonawalla Centre of Excellence in Infectious Diseases and Pandemic Preparedness at Hyderabad.

    This centre will be located at Indian Institute of Public Health, Hyderabad.

    The Centre of Excellence (CoE) is being set up for providing the community with a centralised location for information, resources, and support during times of public health emergencies. The centre will be staffed by experienced healthcare professionals and equipped with state-of-the-art technology and resources.

    The facility will serve as a hub for public health education, outreach, and response efforts during outbreaks of infectious diseases. It will provide real-time information and updates on current epidemics, as well as offer resources and support for those who have been affected.

    The discussion for setting up the Centre had started at Telangana Industry Minister K. T. Rama Rao’s meeting with Adar Poonawalla, CEO – Serum Institute of India during the World Economic Forum in Davos in May 2022. The announcement of this centre was made after Rama Rao held a virtual meeting with Adar Poonawalla on Sunday.

    “The opening of this Centre of Excellence in Infectious Diseases and Pandemic Preparedness marks a significant step forward in our efforts to protect the health and well-being of our community. By centralising our resources and expertise, we can ensure a quick and effective response to any public health emergency. Through this investment, I am delighted to welcome Serum Institute of India (SII), which is the largest vaccine manufacturer, to the city of Hyderabad that is regarded as the vaccine capital of the world,” said Rama Rao.

    Adar Poonawalla said that the Dr Cyrus Poonawalla CoE for Infectious Diseases and Pandemic Preparedness will offer a variety of services, including public health education and outreach, monitoring and tracking of infectious diseases, coordination of response efforts with local healthcare providers, provision of information and support for individuals and families affected by epidemic.

    Prof Srinath Reddy, Indian Institute of Public Health Hyderabad, said that the CoE will help to strengthen India’s capacity to anticipate, avert and attenuate pandemic threats through improved prevention, prediction, preparation and prompt response.

    “Other infectious diseases of concern too will be addressed through a public health guided multi-sectoral response. PHFI welcomes this initiative that will place IIPH-Hyderabad at the frontline of infectious disease prevention and control,” he said

    The Indian Institute of Public Health (IIPH-H) is one of five institutions established by the Public Health Foundation of (PHFI) across the country, to strengthen health systems for better planning and performance and also align multi-sectoral policies and programmes to public health objectives.

    Serum Institute of India Pvt. Ltd. is the world’s largest vaccine manufacturer by number of doses produced and sold globally (more than 1.5 billion doses) which includes Polio vaccine, Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, Rubella as well as Pneumococcal and Covid-19 vaccines.

    [ad_2]
    #Hyderabad #Serum #Institute #set #CoE #infectious #diseases #pandemic #preparedness

    ( With inputs from www.siasat.com )